ALK positivity, defined based on an immunoreactivity score that takes both the intensity and the fraction of positive tumor cells into account, was identified in 12 tumors (1.5 %), including 11 adenocarcinomas and one non-small cell carcinoma NOS. The gene discussed is ALK; the disease is adenocarcinoma.